CARBIDOPA, LEVODOPA, AND ENTACAPONE

481 reported adverse events

Drug classes: Aromatic Amino Acid Decarboxylation Inhibitor [EPC] Aromatic Amino Acid [EPC] Catechol-O-Methyltransferase Inhibitor [EPC]

These side effects are most commonly reported by patients taking CARBIDOPA, LEVODOPA, AND ENTACAPONE:

# Side effect Count
0 FALL 69
1 DEATH 54
2 HALLUCINATION 52
3 DRUG INEFFECTIVE 43
4 PARKINSON^S DISEASE 41
5 DYSKINESIA 27
6 URINARY TRACT INFECTION 27
7 PRODUCT DOSE OMISSION ISSUE 25
8 CONFUSIONAL STATE 24
9 DEVICE ISSUE 21
See all common reactions for CARBIDOPA, LEVODOPA, AND ENTACAPONE

CARBIDOPA, LEVODOPA, AND ENTACAPONE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 STOMA SITE EXTRAVASATION 8 0.0207
1 STOMA SITE ABSCESS 3 0.0123
2 STOMA SITE IRRITATION 5 0.0092
3 STOMA SITE HYPERGRANULATION 5 0.0079
4 MEDICAL DEVICE SITE PAIN 4 0.0071
5 DEEP BRAIN STIMULATION 4 0.0066
6 STOMA SITE PAIN 8 0.0054
7 STOMA SITE ERYTHEMA 10 0.0053
8 INTENTIONAL MEDICAL DEVICE REMOVAL BY PATIENT 5 0.0050
9 DEVICE COLOUR ISSUE 2 0.0050
See all enriched reactions for CARBIDOPA, LEVODOPA, AND ENTACAPONE